Skip to main content
VNRX logo

VolitionRx Limited

VNRXNYSEAMERICANHealthcareMedical Devices

$0.19Today:- (-)1Y −60.21%

As of Oct 27, 2026 close

Market cap
$1.69M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$0.17$6.30
Volume (live)
-
Avg. volume (3M)
2.50M

VolitionRx (VNRX) Cash Flow Statement

In fiscal 2025 (fiscal year ended Mar 31, 2026), VolitionRx used $19.68M of cash in operating activities and spent $89.56K on capital expenditures. That left free cash flow of −$19.77M.

VolitionRx Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for VolitionRx Limited (VNRX) - Annual data in millions USD
BreakdownFY 2025FY 2025FY 2024FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingMar 2026Dec 2025Mar 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Operating Activities
Net Income-23.36-23.50-27.26-27.26-35.68-30.60-26.99-20.40-16.10-18.01-14.77
Depreciation & Amortization1.220.981.341.341.151.190.951.040.900.640.53
Deferred Income Tax0.00-0.00-0.000.000.000.000.000.000.04
Stock Based Compensation1.741.741.271.272.293.115.121.731.462.592.44
Change in Working Capital-0.89-0.89-1.25-1.2514.1411.02-0.161.460.790.05-0.48
Change in Accounts Receivable-0.21-0.210.130.13-0.17-0.07-0.01-0.010.000.000.00
Change in Accounts Payable0.080.08-1.22-1.221.220.550.522.051.110.10-0.34
Change in Other Working Capital-0.76-0.21-0.16-0.060.0910.54-0.69-0.58-0.31-0.02-0.14
Other Operating Activities1.601.980.010.230.040.000.23-0.290.210.000.05
Net Cash from Operating Activities-19.68-19.68-25.89-25.89-18.06-15.28-20.85-16.46-12.74-14.73-12.19
Investing Activities
Capital Expenditures-0.09-0.09-0.57-0.57-1.08-1.57-0.97-1.94-0.51-0.30-1.43
Sales/Maturities of Investments0.00-0.00-0.300.000.000.000.000.000.000.00
Other Investing Activities0.00--0.30-0.000.000.000.290.000.000.00
Net Cash from Investing Activities-0.09-0.09-0.57-0.57-1.08-1.57-0.97-1.65-0.51-0.30-1.43
Financing Activities
Debt Repayment6.02-1.710.23-1.14-1.050.21-0.80-0.300.34-0.481.01
Common Stock Issued11.1711.178.598.5928.396.7423.2221.2016.5917.251.00
Common Stock Repurchased0.00-0.210.00-0.14-0.240.00-0.13-0.050.000.000.00
Other Financing Activities-0.100.11-0.17-0.170.00-0.01-0.01-0.22-0.01-0.14-0.05
Net Cash from Financing Activities17.0917.098.668.6628.986.9422.8620.6216.9317.971.97
Summary
Effect of Forex Changes on Cash0.530.530.340.340.030.200.11-0.03-0.140.380.09
Net Change in Cash-2.15-2.15-17.47-17.479.86-9.711.142.483.543.31-11.56
Cash at Beginning of Period3.263.2620.7320.7310.8720.5819.4416.9713.4310.1221.68
Cash at End of Period1.121.123.263.2620.7310.8720.5819.4416.9713.4310.12
Free Cash Flow-19.77-19.77-26.47-26.47-19.15-16.85-21.83-18.41-13.25-15.03-13.62
Supplemental Disclosures
Interest Paid---0.340.220.170.160.13---

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About VolitionRx Cash Flow

What is VolitionRx's free cash flow?

VolitionRx had negative free cash flow of $19.77M in fiscal 2025 (fiscal year ended Mar 31, 2026), operating cash flow of −$19.68M minus $89.56K of capital expenditures.

How much does VolitionRx spend on capital expenditures?

VolitionRx spent $89.56K on capital expenditures in fiscal 2025, compared with $573.85K a year earlier.

Does VolitionRx pay dividends or buy back shares?

VolitionRx's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition